Search research articles
Contact Us
Filters
Showing results (71-80 of 158) with videos related to
Page
of 16
Sort By:
Hepatology (Baltimore, Md.)
|
December 17, 2016
Targeting β-catenin in hepatocellular cancers induced by coexpression of mutant β-catenin and K-Ras in mice
Junyan Tao, Rong Zhang, Sucha Singh, et al.
Journal of Hepatology
|
March 26, 2017
Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload
Morgan E Preziosi, Sucha Singh, Erika V Valore, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Western diet dampens T regulatory cell function to fuel hepatic inflammation in nonalcoholic fatty liver disease
Sudrishti Chaudhary, Ravi Rai, Pabitra B Pal, et al.
Biochimica Et Biophysica Acta
|
July 3, 2016
Terminal regions of β-catenin are critical for regulating its adhesion and transcription functions
Mohd Saleem Dar, Paramjeet Singh, Gurjinder Singh, et al.
The American Journal of Pathology
|
July 3, 2020
Hepatic Stellate Cell-Specific Platelet-Derived Growth Factor Receptor-α Loss Reduces Fibrosis and Promotes Repair after Hepatocellular Injury
Alexander Kikuchi, Sucha Singh, Minakshi Poddar, et al.
Hepatology (Baltimore, Md.)
|
September 15, 2018
Hepatocyte-Specific β-Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes
Jacquelyn O Russell, Wei-Yu Lu, Hirohisa Okabe, et al.
Scientific Reports
|
October 28, 2020
Impaired mitochondrial medium-chain fatty acid oxidation drives periportal macrovesicular steatosis in sirtuin-5 knockout mice
Eric S Goetzman, Sivakama S Bharathi, Yuxun Zhang, et al.
The American Journal of Pathology
|
August 16, 2017
Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer
Elisabetta Puliga, Qian Min, Junyan Tao, et al.
American Journal of Clinical Oncology
|
August 24, 2000
Intratumoral therapy of cisplatin/epinephrine injectable gel for palliation in patients with obstructive esophageal cancer
S P Monga, R Wadleigh, A Sharma, et al.
Hepatology Communications
|
March 18, 2024
Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editing
Muhamuda Kader, Wei Sun, Bao-Guo Ren, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 158) with videos related to
Sort By:
Page
of 16
Hepatology (Baltimore, Md.)
|
December 17, 2016
Targeting β-catenin in hepatocellular cancers induced by coexpression of mutant β-catenin and K-Ras in mice
Junyan Tao, Rong Zhang, Sucha Singh, et al.
Journal of Hepatology
|
March 26, 2017
Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload
Morgan E Preziosi, Sucha Singh, Erika V Valore, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Western diet dampens T regulatory cell function to fuel hepatic inflammation in nonalcoholic fatty liver disease
Sudrishti Chaudhary, Ravi Rai, Pabitra B Pal, et al.
Biochimica Et Biophysica Acta
|
July 3, 2016
Terminal regions of β-catenin are critical for regulating its adhesion and transcription functions
Mohd Saleem Dar, Paramjeet Singh, Gurjinder Singh, et al.
The American Journal of Pathology
|
July 3, 2020
Hepatic Stellate Cell-Specific Platelet-Derived Growth Factor Receptor-α Loss Reduces Fibrosis and Promotes Repair after Hepatocellular Injury
Alexander Kikuchi, Sucha Singh, Minakshi Poddar, et al.
Hepatology (Baltimore, Md.)
|
September 15, 2018
Hepatocyte-Specific β-Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes
Jacquelyn O Russell, Wei-Yu Lu, Hirohisa Okabe, et al.
Scientific Reports
|
October 28, 2020
Impaired mitochondrial medium-chain fatty acid oxidation drives periportal macrovesicular steatosis in sirtuin-5 knockout mice
Eric S Goetzman, Sivakama S Bharathi, Yuxun Zhang, et al.
The American Journal of Pathology
|
August 16, 2017
Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer
Elisabetta Puliga, Qian Min, Junyan Tao, et al.
American Journal of Clinical Oncology
|
August 24, 2000
Intratumoral therapy of cisplatin/epinephrine injectable gel for palliation in patients with obstructive esophageal cancer
S P Monga, R Wadleigh, A Sharma, et al.
Hepatology Communications
|
March 18, 2024
Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editing
Muhamuda Kader, Wei Sun, Bao-Guo Ren, et al.
Page
of 16